Where I see patients (2)
IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes.
The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes.
Simplifying prediction of disease progression in pre-symptomatic type 1 diabetes using a single blood sample.
Type 1 Diabetes Extension Study
Evaluation of changes in beta cell function over time will be measured by mixed-meal tolerance test (MMTT) -Stimulated mean C-Peptide area under the curve (AUC). C-peptide is released by the pancreas into the bloodstream in equal...
Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus
The primary outcome is the time from treatment assignment to changes in glucose tolerance. The time to development of abnormal glucose tolerance or the diagnosis of type 1 diabetes will be measured to identify these changes.
Fetal surgery firsts